Furthermore, high CEP55 expression suggested shorter DFI for patients with certain cancers (KIRP, LIHC, LUAD, PAAD, SARC, and THCA) and shorter PFI for those suffering from ACC, ESCA, KICH, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PCPG, PRAD, SARC, and UVM (HR > 1, p < 0.05; Fig. 4A–D). This evidence concerns the gene CEP55 and adrenal cortex carcinoma.